Fri, April 26, 2019
Thu, April 25, 2019
Wed, April 24, 2019
Tue, April 23, 2019
Mon, April 22, 2019
Thu, April 18, 2019
Wed, April 17, 2019
Tue, April 16, 2019
Mon, April 15, 2019
Fri, April 12, 2019
Thu, April 11, 2019
Wed, April 10, 2019
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019

Do Kim Maintained (ALNY) at Buy with Increased Target to $126 on, Apr 15th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-126-on-apr-15th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $119 to $126 on, Apr 15th, 2019.

Do has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with Do's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $70 on, Tuesday, April 9th, 2019
  • Esther Rajavelu of "UBS" Initiated at Hold on, Wednesday, January 23rd, 2019


This is the rating of the analyst that currently disagrees with Do


  • David Lebovitz of "Morgan Stanley" Upgraded from Hold to Buy on, Tuesday, March 5th, 2019

Publication Contributing Sources